mitomycin has been researched along with Nasopharyngeal Carcinoma in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to investigate the inhibitory effects of mitomycin C (MMC) combined with a novel antibody fragment (Fab) targeting latent membrane protein 1 (LMP1) on nasopharyngeal carcinoma (NPC) xenograft nude mice." | 7.78 | A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor. ( Cao, Q; Chen, RJ; Feng, ZQ; Mao, Y; Wen, J; Zhang, DW; Zhu, J, 2012) |
| " The aim of this study was to investigate the inhibitory effects of mitomycin C (MMC) combined with a novel antibody fragment (Fab) targeting latent membrane protein 1 (LMP1) on nasopharyngeal carcinoma (NPC) xenograft nude mice." | 3.78 | A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor. ( Cao, Q; Chen, RJ; Feng, ZQ; Mao, Y; Wen, J; Zhang, DW; Zhu, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, X | 1 |
| Zhang, Q | 1 |
| Tian, L | 1 |
| Guo, Z | 1 |
| Liu, C | 1 |
| Chen, J | 1 |
| Ebrahim, W | 1 |
| Liu, Z | 1 |
| Proksch, P | 1 |
| Zou, K | 1 |
| Huang, J | 1 |
| Li, Q | 1 |
| Zheng, Y | 1 |
| Shen, J | 1 |
| Li, B | 1 |
| Zou, R | 1 |
| Wang, J | 1 |
| Yuan, Y | 1 |
| Chen, R | 1 |
| Zhang, D | 1 |
| Mao, Y | 2 |
| Zhu, J | 2 |
| Ming, H | 1 |
| Wen, J | 2 |
| Ma, J | 1 |
| Cao, Q | 2 |
| Lin, H | 1 |
| Tang, Q | 1 |
| Liang, J | 1 |
| Feng, Z | 1 |
| Zhang, DW | 1 |
| Chen, RJ | 1 |
| Feng, ZQ | 1 |
1 review available for mitomycin and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoembolization, Th | 2014 |
3 other studies available for mitomycin and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Germacrane-Type Sesquiterpenoids with Antiproliferative Activities from Eupatorium chinense.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Ce | 2018 |
A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Carcinoma; Cell Line, Tumor; Cell Prolifer | 2012 |
A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor.
Topics: Animals; Antibodies; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Dr | 2012 |